Mode of recovery from the effects of heterologous anti-lymphocyte serum. I. Recovery of the immune response.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects*; D000961:Antilymphocyte Serum / Q000032:analysis / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D006084:Graft Rejection; D006736:Horses; D051379:Mice; D011817:Rabbits; D012756:Sheep; D016038:Skin Transplantation; D013154:Spleen / Q000276:immunology / Q000637:transplantation; D013997:Time Factors; D014184:Transplantation, Homologous
D000906:Antibodies; D000961:Antilymphocyte Serum; D003520:Cyclophosphamide